KIMS · Healthcare
Krishna Institute of Medical Sciences Ltd. reported revenue of ₹634 cr for January to March 2024, — on the year and +4.6% on the quarter.
Operating profit (EBITDA) was ₹159 cr, a margin of 25.1%, — on the year and +82 bps on the quarter.
Net profit was ₹72.0 cr, — on the year and −6.5% on the quarter, with earnings per share of ₹1.64.
On earnings per share of ₹7.76 over the last four quarters, the stock at ₹720.75 trades at 92.9 times trailing earnings.
Written from the quarterly statements. The filing read adds the balance sheet and cash flow filed with this quarter, the auditor's review, segment results, one-off items line by line and what management said on the call.
No check fired. That is a statement about the checks below, not a verdict on the company.
Could not run on this quarter: Headline vs core profit, Exceptional items that recur, Operating margin on the year, Depreciation falling, Finance cost rising, Swing to loss or profit, Cash behind the profit, Receivables against sales, Inventory against sales, Borrowing while holding cash, Auditor's review or audit report, IPO money used as stated, Related-party transactions, Exits, postponements, restatements, Promoter pledges and allotments, Earlier promises against delivery, When the results were filed. Most need the filing read (balance sheet, cash flow, auditor, disclosures).
This quarter's filing carries a balance sheet and a cash flow statement. The cash, receivables and borrowing checks run once the filing read is in.
| Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹606 cr | ₹634 cr | ₹688 cr | ₹777 cr | ₹772 cr | ₹797 cr | ₹872 cr | ₹961 cr | ₹998 cr | ₹1,075 cr | ₹1,180 cr | ₹1,344 cr |
| YoY | — | — | +14% | +19% | +27% | +26% | +27% | +24% | +29% | +35% | +35% | +40% |
| EBITDA margin | 24.3% | 25.1% | 26.0% | 28.1% | 24.2% | 24.8% | 22.1% | 21.2% | 19.9% | 19.2% | 18.9% | 19.3% |
| Other income, % of PBT | 3% | 4% | 4% | 3% | 13% | 11% | 6% | 4% | 7% | 2% | 30% | 30% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 25% | 28% | 25% | 26% | 31% | 21% | 25% | 26% | 24% | 40% | 34% | 29% |
| Net profit | ₹77.0 cr | ₹72.0 cr | ₹95.0 cr | ₹121 cr | ₹92.0 cr | ₹106 cr | ₹85.0 cr | ₹72.0 cr | ₹52.0 cr | ₹33.0 cr | ₹37.0 cr | ₹75.0 cr |
| YoY | — | — | +9% | +20% | +19% | +47% | −11% | −40% | −43% | −69% | −56% | +4% |
| Core profit YoY | — | — | +5% | +15% | +18% | +24% | −12% | −41% | −45% | −55% | −63% | −20% |
| EPS | ₹1.80 | ₹1.64 | ₹2.16 | ₹2.68 | ₹2.22 | ₹2.54 | ₹1.96 | ₹1.67 | ₹1.33 | ₹1.06 | ₹0.99 | ₹1.79 |
| Flags | · | · | ✓ | ✓ | ✓ | 1 | 2 | 2 | 2 | 2 | 2 | 3 |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Krishna Institute of Medical Sciences Ltd. reported revenue of ₹634 cr (— on the year) and net profit of ₹72.0 cr (— on the year) for January to March 2024.
None of the 2 checks that could run raised a question.
No. FinMinutes reports what was filed and the questions the numbers raise. It does not recommend buying, selling or holding any security.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.